Lokavant's Innovative Impact on Clinical Trials
Lokavant, a top player in clinical trial intelligence, is thrilled to announce a presentation focused on the effects of next-generation Causal AI on the feasibility of clinical trials. This event will be featured at the DPHARM 2024 Innovations Conference, showcasing significant advancements in the realm of clinical research.
Exploring Causal AI in Clinical Trials
Aaron Mackey, the Senior Vice President of AI and Development at Lokavant, will share valuable insights regarding Causal AI. This cutting-edge technology streamlines the feasibility assessments of clinical trials, guiding sponsors in making informed choices that keep their studies on track. Mackey's practical approach aims to illustrate how artificial intelligence can dramatically improve the efficiency of clinical trial operations.
The Challenges in Clinical Trial Feasibility
Research reveals that nearly 80% of feasibility assessments in clinical trials struggle with insufficient data collection methods, which leads to unreliable predictions. These obstacles can result in delays and inefficient resource use during trials. Lokavant tackles these problems directly with its Spectrum feasibility software, enabling study teams to predict, optimize, and manage trial timelines and expenses in real-time.
Transforming Clinical Trials with Spectrum
Spectrum, part of Lokavant's Clinical Intelligence Platform, utilizes Causal AI to offer actionable insights. This innovative software not only foresees potential challenges but also allows adjustments throughout the study’s lifecycle. Importantly, it can adapt to changes such as protocol amendments, which have become more frequent in recent years, highlighting a need for flexible solutions.
Impressive Results from Lokavant’s Platform
A major benefit of Lokavant’s platform is its vast database of historical trial data, drawn from over 2,000 studies and contributions by more than 14,000 investigators. This extensive input provides real-time visibility into trial performance, significantly improving the accuracy of feasibility assessments and enhancing decision-making processes.
A Vision for the Future
During the upcoming presentation, Mackey will explain how Causal AI acts as a catalyst for elevating clinical trial efficiency and speed. By addressing operational hurdles with cutting-edge technology solutions, clinical trial teams can make crucial decisions more swiftly, thus accelerating the drug development process. Lokavant is dedicated to this mission, harnessing AI to boost human capabilities and streamline clinical workflows.
Join Lokavant at DPHARM 2024
Participants can anticipate an informative discussion on the advantages of Causal AI and the transformative features of the Spectrum solution at the DPHARM 2024 conference. The presentation is planned for Tuesday, September 17, from 12:05 to 12:35 PM EST. This event is a valuable chance for stakeholders in the clinical trial field to discover advanced methodologies that can significantly enhance operational outcomes.
About Lokavant
Lokavant is focused on transforming the clinical trial landscape through its AI-driven Clinical Intelligence Platform. With the Spectrum solution, study teams are better equipped to refine their feasibility assessments and trial management. This platform, rich with proprietary data, enables organizations to adapt quickly to the ever-changing demands of contemporary clinical research. Lokavant is committed to reshaping clinical studies with intelligent technologies that enhance existing systems and boost the efficiency of clinical trials.
Frequently Asked Questions
What does Lokavant primarily offer?
Lokavant delivers a Clinical Intelligence Platform designed to improve clinical trial feasibility and execution through advanced AI technologies.
How does Causal AI contribute to clinical trials?
Causal AI optimizes feasibility assessments, allowing sponsors to make well-informed decisions throughout the trial process.
What are some common challenges faced by clinical trials?
Frequent challenges include inadequate data collection methods, slow trial execution, and ongoing protocol amendments, which can lead to inefficiencies.
In what ways can Lokavant's Spectrum software enhance trials?
Spectrum offers real-time predictions and optimizations for trial timelines and costs, enabling continuous adjustments when needed throughout the study.
When will Lokavant present at DPHARM 2024?
The presentation is set for Tuesday, September 17, from 12:05 to 12:35 PM EST, during the DPHARM 2024 conference.
